MAN2A2
Basic information
Region (hg38): 15:90902218-90922584
Links
Phenotypes
GenCC
Source:
- disorder of glycosylation (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAN2A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 113 | 120 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 113 | 7 | 4 |
Variants in MAN2A2
This is a list of pathogenic ClinVar variants found in the MAN2A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-90904279-C-T | Benign (Feb 24, 2021) | |||
15-90904281-T-C | not specified | Uncertain significance (Dec 09, 2024) | ||
15-90904337-C-G | not specified | Uncertain significance (Jul 14, 2024) | ||
15-90905330-T-G | not specified | Uncertain significance (May 24, 2023) | ||
15-90905361-C-A | not specified | Uncertain significance (Dec 14, 2023) | ||
15-90905471-T-G | not specified | Uncertain significance (Sep 07, 2022) | ||
15-90905485-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
15-90905486-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
15-90905489-G-T | not specified | Uncertain significance (Mar 23, 2023) | ||
15-90905579-A-G | not specified | Uncertain significance (Jun 09, 2022) | ||
15-90905583-T-C | not specified | Uncertain significance (Dec 21, 2022) | ||
15-90905642-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
15-90905645-G-A | not specified | Uncertain significance (Nov 11, 2024) | ||
15-90905661-C-T | not specified | Uncertain significance (Dec 06, 2024) | ||
15-90905666-G-A | Aganglionic megacolon | Uncertain significance (May 16, 2019) | ||
15-90905932-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
15-90905938-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
15-90905967-G-A | not specified | Uncertain significance (Nov 11, 2024) | ||
15-90905989-A-G | not specified | Likely benign (Jun 07, 2024) | ||
15-90906004-C-G | not specified | Uncertain significance (Nov 26, 2024) | ||
15-90906004-C-T | not specified | Uncertain significance (Aug 20, 2024) | ||
15-90906382-C-G | not specified | Uncertain significance (Jun 30, 2022) | ||
15-90906399-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
15-90906491-A-C | not specified | Uncertain significance (Oct 26, 2021) | ||
15-90906746-C-T | not specified | Uncertain significance (Nov 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAN2A2 | protein_coding | protein_coding | ENST00000360468 | 22 | 20367 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.50e-10 | 1.00 | 125361 | 0 | 387 | 125748 | 0.00154 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.05 | 650 | 730 | 0.891 | 0.0000471 | 7476 |
Missense in Polyphen | 221 | 294.27 | 0.751 | 3174 | ||
Synonymous | -1.45 | 336 | 304 | 1.11 | 0.0000199 | 2367 |
Loss of Function | 3.96 | 27 | 60.1 | 0.449 | 0.00000343 | 583 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00361 | 0.00338 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.000324 | 0.000323 |
European (Non-Finnish) | 0.00204 | 0.00204 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000458 | 0.000457 |
Other | 0.00293 | 0.00294 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the first committed step in the biosynthesis of complex N-glycans. It controls conversion of high mannose to complex N-glycans; the final hydrolytic step in the N-glycan maturation pathway.;
- Pathway
- N-Glycan biosynthesis - Homo sapiens (human);Vesicle-mediated transport;er associated degradation (erad) pathway;Membrane Trafficking;Post-translational protein modification;Reactions specific to the complex N-glycan synthesis pathway;N-glycan antennae elongation in the medial/trans-Golgi;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Intra-Golgi traffic;N-Glycan biosynthesis;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.285
- rvis_EVS
- -1.45
- rvis_percentile_EVS
- 3.93
Haploinsufficiency Scores
- pHI
- 0.133
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.461
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.938
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Man2a2
- Phenotype
- renal/urinary system phenotype; respiratory system phenotype; liver/biliary system phenotype; endocrine/exocrine gland phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- mannose metabolic process;protein glycosylation;N-glycan processing;protein deglycosylation
- Cellular component
- Golgi membrane;integral component of membrane
- Molecular function
- alpha-mannosidase activity;mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity;hydrolase activity, hydrolyzing N-glycosyl compounds;carbohydrate binding;metal ion binding